• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用全球触发工具描述瑞士住院肿瘤患者的不良事件。

Describing adverse events in Swiss hospitalized oncology patients using the Global Trigger Tool.

作者信息

Gerber Anne, Da Silva Lopes André, Szüts Natacha, Simon Michael, Ribordy-Baudat Viviane, Ebneter Andreas, Perrinjaquet Claire, Gaignard Marie-Estelle, Nicodet Delphine, Betticher Daniel, Bula Grégoire, Cote Maxime, Duchosal Michel André, Berret Pierre-André, Dietrich Pierre-Yves, Brennan Caitlin, Decosterd Sandy, Ferreira Nobre Sandrina, Peters Solange, Koelliker Reto, Ninane Françoise, Jeitziner Marie-Madlen, Colomer-Lahiguera Sara, Eicher Manuela

机构信息

School of Health Sciences (HESAV) University of Applied Sciences and Arts Western Switzerland (HES-SO) Lausanne Switzerland.

Institute of Higher Education and Research in Healthcare (IUFRS) Faculty of Biology and Medicine, University of Lausanne Lausanne Switzerland.

出版信息

Health Sci Rep. 2020 May 12;3(2):e160. doi: 10.1002/hsr2.160. eCollection 2020 Jun.

DOI:10.1002/hsr2.160
PMID:32405540
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7217322/
Abstract

BACKGROUND AND AIMS

The occurrence rate of adverse events (AEs) related to care among hospitalized oncology patients in Switzerland remains unknown. The primary objective of this study was to describe, for the first time, the occurrence rate, type, severity of harm, and preventability of AEs related to care, reported in health records of hospitalized hematological and solid-tumor cancer patients in three Swiss hospitals.

METHODS

Using an adapted version of the validated Global Trigger Tool (GTT) from the Institute for Healthcare Improvement, we conducted a retrospective record review of patients discharged from oncology units over a 6-week period during 2018. Our convenience sample included all records from adult patients (≥18 years of age), diagnosed with cancer, and hospitalized (>24 hours). Per the GTT method, two trained nurses independently assessed patient records to identify AEs using triggers, and physicians from the included units analyzed the consensus of the two nurses. Together, they assessed the severity and preventability of each AE.

RESULTS

From the sample of 224 reviewed records, we identified 661 triggers and 169 AEs in 94 of them (42%). Pain related to care was the most frequent AE (n = 29), followed by constipation (n = 17). AEs rates were 75.4 per 100 admissions and 106.6 per 1000 patient days. Most of the identified AEs (78%) caused temporary harm to the patient and required an intervention. Among AEs during hospitalization (n = 125), 76 (61%) were considered not preventable, 28 (22%) preventable, and 21 (17%) undetermined.

CONCLUSION

About half of the hospitalized oncology patients suffered from at least one AE related to care during their hospitalization. Pain, constipation, and nosocomial infections were the most frequent AEs. It is, therefore, essential to identify AEs to guide future clinical practice initiatives to ensure patient safety.

摘要

背景与目的

瑞士住院肿瘤患者中与护理相关的不良事件(AE)发生率尚不清楚。本研究的主要目的是首次描述瑞士三家医院住院血液肿瘤和实体肿瘤癌症患者健康记录中报告的与护理相关的不良事件的发生率、类型、伤害严重程度和可预防性。

方法

我们使用了医疗改进研究所经过验证的全球触发工具(GTT)的改编版本,对2018年6周内从肿瘤科出院的患者进行了回顾性记录审查。我们的便利样本包括所有成年患者(≥18岁)的记录,这些患者被诊断患有癌症并住院(>24小时)。根据GTT方法,两名经过培训的护士独立评估患者记录以使用触发因素识别不良事件,纳入科室的医生分析两名护士的共识。他们共同评估了每个不良事件的严重程度和可预防性。

结果

在224份审查记录的样本中,我们识别出661个触发因素,其中94份记录(42%)中有169例不良事件。与护理相关的疼痛是最常见的不良事件(n = 29),其次是便秘(n = 17)。不良事件发生率为每100次入院75.4例,每1000个患者日106.6例。大多数已识别的不良事件(78%)对患者造成了暂时伤害,需要进行干预。在住院期间的不良事件(n = 125)中,76例(61%)被认为不可预防,28例(22%)可预防,21例(17%)未确定。

结论

约一半的住院肿瘤患者在住院期间至少遭受了一次与护理相关的不良事件。疼痛、便秘和医院感染是最常见의不良事件。因此,识别不良事件对于指导未来的临床实践举措以确保患者安全至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cee/7217322/c901968a6525/HSR2-3-e160-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cee/7217322/ead74df00881/HSR2-3-e160-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cee/7217322/91dd31591029/HSR2-3-e160-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cee/7217322/d39157f6bbb0/HSR2-3-e160-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cee/7217322/c901968a6525/HSR2-3-e160-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cee/7217322/ead74df00881/HSR2-3-e160-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cee/7217322/91dd31591029/HSR2-3-e160-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cee/7217322/d39157f6bbb0/HSR2-3-e160-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cee/7217322/c901968a6525/HSR2-3-e160-g004.jpg

相似文献

1
Describing adverse events in Swiss hospitalized oncology patients using the Global Trigger Tool.使用全球触发工具描述瑞士住院肿瘤患者的不良事件。
Health Sci Rep. 2020 May 12;3(2):e160. doi: 10.1002/hsr2.160. eCollection 2020 Jun.
2
Describing adverse events in medical inpatients using the Global Trigger Tool.使用全球触发工具描述住院患者的不良事件。
Swiss Med Wkly. 2019 Nov 10;149:w20149. doi: 10.4414/smw.2019.20149. eCollection 2019 Nov 4.
3
Comparison of a Voluntary Safety Reporting System to a Global Trigger Tool for Identifying Adverse Events in an Oncology Population.比较自愿安全报告系统与全球触发工具,以识别肿瘤患者中的不良事件。
J Patient Saf. 2022 Sep 1;18(6):611-616. doi: 10.1097/PTS.0000000000001050. Epub 2022 Jul 21.
4
5
Validation of triggers and development of a pediatric trigger tool to identify adverse events.验证触发因素并开发用于识别不良事件的儿科触发工具。
BMC Health Serv Res. 2014 Dec 21;14:655. doi: 10.1186/s12913-014-0655-5.
6
Adverse events identified by the global trigger tool at a university hospital: A retrospective medical record review.全球触发工具在一所大学医院识别的不良事件:回顾性病历审查。
J Evid Based Med. 2019 May;12(2):91-97. doi: 10.1111/jebm.12329. Epub 2018 Dec 3.
7
Development of a Trigger Tool to Identify Adverse Events and Harm in a Neuropsychiatry Setting.开发一种触发工具,以识别神经精神病学环境中的不良事件和伤害。
J Patient Saf. 2022 Jan 1;18(1):e343-e350. doi: 10.1097/PTS.0000000000000784.
8
Characterization of adverse events detected in a large health care delivery system using an enhanced global trigger tool over a five-year interval.利用强化全球触发工具在五年时间间隔内对大型医疗保健提供系统中检测到的不良事件进行特征描述。
Health Serv Res. 2014 Oct;49(5):1407-25. doi: 10.1111/1475-6773.12163. Epub 2014 Mar 13.
9
Incidence of adverse events in Sweden during 2013-2016: a cohort study describing the implementation of a national trigger tool.2013 - 2016年瑞典不良事件的发生率:一项描述国家触发工具实施情况的队列研究
BMJ Open. 2018 Mar 30;8(3):e020833. doi: 10.1136/bmjopen-2017-020833.
10
Assessment of the reliability of the IHI Global Trigger Tool: new perspectives from a Brazilian study.评估 IHI 全球触发工具的可靠性:来自巴西研究的新视角。
Int J Qual Health Care. 2021 Mar 18;33(1). doi: 10.1093/intqhc/mzab039.

引用本文的文献

1
Invisible harm in patient safety: a framework and definition for preventable psychological harm in cancer care.患者安全中的无形伤害:癌症护理中可预防心理伤害的框架与定义
BMJ Open Qual. 2025 Aug 26;14(3):e003466. doi: 10.1136/bmjoq-2025-003466.
2
Assessment of the occurrence of adverse events through the global trigger tool in a university hospital in Italy.通过全球触发工具对意大利一家大学医院不良事件的发生情况进行评估。
Sci Rep. 2025 Jul 4;15(1):23973. doi: 10.1038/s41598-025-08617-8.
3
The application of Global Trigger Tool in monitoring antineoplastic adverse drug events: a retrospective study.

本文引用的文献

1
Developing a cancer-specific trigger tool to identify treatment-related adverse events using administrative data.开发一种癌症特异性触发工具,以使用行政数据识别与治疗相关的不良事件。
Cancer Med. 2020 Feb;9(4):1462-1472. doi: 10.1002/cam4.2812. Epub 2020 Jan 3.
2
Describing adverse events in medical inpatients using the Global Trigger Tool.使用全球触发工具描述住院患者的不良事件。
Swiss Med Wkly. 2019 Nov 10;149:w20149. doi: 10.4414/smw.2019.20149. eCollection 2019 Nov 4.
3
Distress Management, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.
全球触发工具在监测抗肿瘤药物不良事件中的应用:一项回顾性研究。
Front Oncol. 2024 May 8;14:1230514. doi: 10.3389/fonc.2024.1230514. eCollection 2024.
4
[Update of triggers for detection of adverse drug events in hematologic patients].[血液学患者不良药物事件检测触发因素的更新]
Cad Saude Publica. 2023 Dec 22;39(12):e00077923. doi: 10.1590/0102-311XPT077923. eCollection 2023.
5
Comparing rates of adverse events detected in incident reporting and the Global Trigger Tool: a systematic review.比较不良事件在不良事件报告和全球触发工具中检测到的发生率:系统评价。
Int J Qual Health Care. 2023 Jul 25;35(3). doi: 10.1093/intqhc/mzad056.
6
Clinical and economic impact of clinical oncology pharmacy in cancer patients receiving injectable anticancer treatments: a systematic review.癌症患者接受注射用抗肿瘤药物治疗时临床肿瘤药学的临床和经济影响:系统评价。
J Cancer Res Clin Oncol. 2023 Aug;149(10):7905-7924. doi: 10.1007/s00432-023-04630-4. Epub 2023 Feb 28.
7
Variation in detected adverse events using trigger tools: A systematic review and meta-analysis.使用触发工具检测到的不良事件的变化:系统评价和荟萃分析。
PLoS One. 2022 Sep 1;17(9):e0273800. doi: 10.1371/journal.pone.0273800. eCollection 2022.
8
A Risk-Factor Model for Antineoplastic Drug-Induced Serious Adverse Events in Cancer Inpatients: A Retrospective Study Based on the Global Trigger Tool and Machine Learning.癌症住院患者抗肿瘤药物所致严重不良事件的风险因素模型:一项基于全球触发工具和机器学习的回顾性研究
Front Pharmacol. 2022 Jun 29;13:896104. doi: 10.3389/fphar.2022.896104. eCollection 2022.
9
Incidence, severity, and preventability of adverse events during the induction of patients with acute lymphoblastic leukemia in a tertiary care pediatric hospital in Mexico.墨西哥一家三级儿科医院中急性淋巴细胞白血病患者诱导期不良事件的发生率、严重程度和可预防程度。
PLoS One. 2022 Mar 24;17(3):e0265450. doi: 10.1371/journal.pone.0265450. eCollection 2022.
10
Occurrence of No-Harm Incidents and Adverse Events in Hospitalized Patients with Ischemic Stroke or TIA: A Cohort Study Using Trigger Tool Methodology.缺血性卒中和 TIA 住院患者中无伤害事件和不良事件的发生:使用触发工具方法的队列研究。
Int J Environ Res Public Health. 2022 Feb 27;19(5):2796. doi: 10.3390/ijerph19052796.
《 distress management 》,版本 3.2019, NCCN 肿瘤临床实践指南。
J Natl Compr Canc Netw. 2019 Oct 1;17(10):1229-1249. doi: 10.6004/jnccn.2019.0048.
4
Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.成人癌症疼痛,第 3.2019 版,NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2019 Aug 1;17(8):977-1007. doi: 10.6004/jnccn.2019.0038.
5
Prevalence, severity, and nature of preventable patient harm across medical care settings: systematic review and meta-analysis.医疗保健环境中可预防的患者伤害的发生率、严重程度和性质:系统评价和荟萃分析。
BMJ. 2019 Jul 17;366:l4185. doi: 10.1136/bmj.l4185.
6
Engaging Patients and Clinicians in Online Reporting of Adverse Effects During Chemotherapy for Cancer: The eRAPID System (Electronic Patient Self-Reporting of Adverse Events: Patient Information and aDvice).参与癌症化疗期间不良反应在线报告的患者和临床医生:eRAPID 系统(电子患者自我报告不良反应:患者信息和建议)。
Med Care. 2019 May;57 Suppl 5 Suppl 1:S59-S65. doi: 10.1097/MLR.0000000000001085.
7
Preventable and mitigable adverse events in cancer care: Measuring risk and harm across the continuum.癌症护理中可预防和可减轻的不良事件:衡量整个连续过程中的风险和危害。
Cancer. 2017 Dec 1;123(23):4728-4736. doi: 10.1002/cncr.30916. Epub 2017 Aug 17.
8
Adverse events related to hospital care: a retrospective medical records review in a Swiss hospital.与医院护理相关的不良事件:瑞士一家医院的回顾性病历审查
Int J Qual Health Care. 2017 Aug 1;29(4):527-533. doi: 10.1093/intqhc/mzx061.
9
Adverse events in hospitalised cancer patients: a comparison to a general hospital population.住院癌症患者的不良事件:与综合医院人群的比较。
Acta Oncol. 2017 Sep;56(9):1218-1223. doi: 10.1080/0284186X.2017.1309063. Epub 2017 Apr 5.
10
Performance of a Trigger Tool for Identifying Adverse Events in Oncology.用于识别肿瘤学不良事件的触发工具的性能
J Oncol Pract. 2017 Mar;13(3):e223-e230. doi: 10.1200/JOP.2016.016634. Epub 2017 Jan 17.